Organomegaly and tumors in transgenic mice with targeted expression of HpaII methyltransferase in smooth muscle cells

Epigenetics

Volumn 6, Issue 3, 2011, Pages 333-343

  Carpinteyro Espín, Paulina ^a   Jacinto Ruíz, Sergio ^a   Caballero Vazquez, Priscilla ^a   Alvarado Caudillo, Yolanda ^a   Lund, Gertrud ^b   Rodríguez Rios, Dalia ^b   Martínez García, Jorge A ^c   Wrobel, Katarzyna ^a   Wrobel, Kazimierz ^a   Zaina, Silvio ^a  

^a UNIVERSITY OF GUANAJUATO   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c Hospital General de Leon   (Mexico)

Author keywords

Cancer; DNA methylation; HpaII methyltransferase; Mouse; Organomegaly; Smooth muscle; Transgenesis

Indexed keywords

DNA; DNA METHYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHROMATIN; CONTROLLED STUDY; CPG ISLAND; DEVELOPMENTAL DISORDER; DNA METHYLATION; FERTILITY; GENE EXPRESSION; GENE FREQUENCY; GENE STRUCTURE; HEMANGIOMA; HYPERPLASIA; INTESTINE CARCINOMA; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGAN WEIGHT; ORGANOGENESIS; PHENOTYPE; PROMOTER REGION; SMOOTH MUSCLE FIBER; TRANSGENE; TRANSGENIC MOUSE; TUMOR; VISCEROMEGALY; WILD TYPE;

ANIMALIA; MAMMALIA; MUS; MUS MUSCULUS; PROKARYOTA;

EID: 79952426342     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.6.3.14089     Document Type: Article

References (43)

1. Ross R, Glomset JA. Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science 1973; 180:1332-9.
2. Stemerman MB, Weinstein R, Rowe JW, Maciag T, Fuhro R, Gardner R. Vascular smooth muscle cell growth kinetics in vivo in aged rats. Proc Natl Acad Sci USA 1982; 79:3863-6.
3. Lagace R, Delage C, Boutet M. Light and electron microscopic study of cellular proliferation in carcinoid heart disease. Recent Adv Stud Cardiac Struct Metab 1975; 10:605-16.
4. Laukkanen MO, Mannermaa S, Hiltunen MO, Aittomäki S, Airenne K, Jänne J, et al. Local hypomethylation in atherosclerosis found in rabbit ec-sod gene. Arterioscler Thromb Vasc Biol 1999; 19:2171-8.
5. Mays-Hoopes LL, Brown A, Huang RC. Methylation and rearrangement of mouse intracisternal a particle genes in development, aging and myeloma. Mol Cell Biol 1983; 3:1371-80.
6. Gallou-Kabani C, Vigé A, Gross MS, Junien C. Nutriepigenomics: lifelong remodelling of our epigenomes by nutritional and metabolic factors and beyond. Clin Chem Lab Med 2007; 45:321-7.
7. Zaina S, Lund G. Epigenetics and Cardiovascular Disease. In: Esteller M, Ed. Epigenetics in Biology and Medicine. London, UK: Taylor & Francis Group LLC 2008; 207-23.
8. Chawla RK, Watson WH, Jones DP. Effect of hypoxia on hepatic DNA methylation and tRNA methyltransferase in rat: similarities to effects of methyl-deficient diets. J Cell Biochem 1996; 61:72-80.
9. Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M, et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet 2006; 38:1378-85.
10. Lyko F, Ramsahoye BH, Kashevsky H, Tudor M, Mastrangelo MA, Orr-Weaver TL, et al. Mammalian (cytosine-5) methyltransferases cause genomic DNA methylation and lethality in Drosophila. Nat Genet 1999; 23:363-6.
11. Takashima S, Takehashi M, Lee J, Chuma S, Okano M, Hata K, et al. Abnormal DNA methyltransferase expression in mouse germline stem cells results in spermatogenic defects. Biol Reprod 2009; 81:155-64.
12. Card CO, Wilson GG, Weule K, Hasapes J, Kiss A, Roberts RJ. Cloning and characterization of the HpaII methylase gene. Nucleic Acids Res 1990; 18:1377-83.
13. Smith AE, Ford KG. Specific targeting of cytosine methylation to DNA sequences in vivo. Nucleic Acids Res 2007; 35:740-54.
14. Smith AE, Hurd PJ, Bannister AJ, Kouzarides T, Ford KG. Heritable gene repression through the action of a directed DNA methyltransferase at a chromosomal locus. J Biol Chem 2008; 283:9878-85.
15. Li F, Papworth M, Minczuk M, Rohde C, Zhang Y, Ragozin S, et al. Chimeric DNA methyltransferases target DNA methylation to specific DNA sequences and repress expression of target genes. Nucleic Acids Res 2007; 35:100-12.
16. Andreas S, Schwenk F, Küter-Luks B, Faust N, Kühn R. Enhanced efficiency through nuclear localization signal fusion on phage C31-integrase: activity comparison with Cre and FLPe recombinase in mammalian cells. Nucleic Acids Res 2002; 30:2299-306.
17. Wang J, Niu W, Nikiforov Y, Naito S, Chernausek S, Witte D, et al. Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice. J Clin Invest 1997; 100:1425-39.
18. Zaina S, Pettersson L, Ahrén B, Brånén L, Hassan AB, Lindholm M, et al. Insulin-like growth factor II plays a central role in atherosclerosis in a mouse model. J Biol Chem 2002; 277:4505-11.
19. Pfaffl MW. Quantification strategies in real-time PCR. In: Bustin SA, Ed. A-Z of quantitative PCR. La Jolla, CA: International University Line (IUL) 2004; 87-112.
20. Alcázar Magaña A, Wrobel K, Alvarado Caudillo Y, Zaina S, Lund G, Wrobel K. High performance liquid chromatography determination of 5-methyl-2'-deoxycytidine (5mdC), 2'-deoxycytidine (dC) and other deoxynucleosides and nucleosides in DNA digests. Anal Biochem 2008; 374:378-85.
21. Lund G, Andersson L, Lauria M, Lindholm M, Fraga MF, Villar-Garea A, et al. DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J Biol Chem 2004; 279:29147-54.
22. Zaina S, Pettersson L, Bloch Thomsen A, Thyberg J, Nilsson J. Shortened life span, bradycardia and hypotension in mice with targeted expression of an Igf2 transgene in smooth muscle cells. Endocrinology 2003; 144:2695-703.
23. Pogribny IP, Beland FA. DNA hypomethylation in the origin and pathogenesis of human diseases. Cell Mol Life Sci 2009; 66:2249-61.
24. Alves G, Tatro A, Fanning T. Differential methylation of human LINE-1 retrotransposons in malignant cells. Gene 1996; 176:39-44.
25. Baust C, Gagnier L, Baillie GJ, Harris MJ, Juriloff DM, Mager DL. Structure and expression of mobile ETnII retroelements and their coding-competent MusD relatives in the mouse. J Virol 2003; 77:11448-58.
26. Maksakova IA, Zhang Y, Mager DL. Preferential epigenetic suppression of the autonomous MusD over the nonautonomous ETn mouse retrotransposons. Mol Cell Biol 2009; 29:2456-68.
27. Eads CA, Lord RV, Kurumboor SK, Wickramasinghe K, Skinner ML, Long TI, et al. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res 2000; 60:5021-6.
28. Otterson GA, Khleif SN, Chen W, Coxon AB, Kaye FJ. CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2'deoxycytidine. Oncogene 1995; 11:1211-6.
29. Herman JG, Umar A, Polyak K, Graff JR, Ahuja N, Issa JP, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA 1998; 95:6870-5.
30. Kim MA, Jung EJ, Lee HS, Lee HE, Yang HK, Oh DY, et al. P-cadherin expression in gastric carcinoma: its regulation mechanism and prognostic significance. Hum Pathol 2010; 41:877-85.
31. Sato N, Maitra A, Fukushima N, van Heek NT, Matsubayashi H, Iacobuzio-Donahue CA, et al. Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma. Cancer Res 2003; 63:4158-66.
32. Kang SH, Bang YJ, Im YH, Yang HK, Lee DA, Lee HY, et al. Transcriptional repression of the transforming growth factor-beta type I receptor gene by DNA methylation results in the development of TGFbeta resistance in human gastric cancer. Oncogene 1999; 18:7280-6.
33. Tsukamoto H, Mishima Y, Hayashibe K, Sasase A. Alpha-smooth muscle actin expression in tumor and stromal cells of benign and malignant human pigment cell tumors. J Invest Dermatol 1992; 98:116-20.
34. McNamara AR, Hurd PJ, Smith AE, Ford KG. Characterisation of site-biased DNA methyltransferases: specificity, affinity and subsite relationships. Nucleic Acids Res 2002; 30:3818-30.
35. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009; 462:315-22.
36. Shevchuk T, Kretzner L, Munson K, Axume J, Clark J, Dyachenko OV, et al. Transgene-induced CCWGG methylation does not alter CG methylation patterning in human kidney cells. Nucleic Acids Res 2005; 33:6124-36.
37. Kanai Y. Alterations of DNA methylation and clinicopathological diversity of human cancers. Pathol Int 2008; 58:544-58.
38. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, et al. Induction of tumors in mice by genomic hypomethylation. Science 2003; 300:489-92.
39. Turunen MP, Aavik E, Ylä-Herttuala S. Epigenetics and atherosclerosis. Biochim Biophys Acta 2009; 1790:886-91.
40. Lee HS, Kim BH, Cho NY, Yoo EJ, Choi M, Shin SH, et al. Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma. Clin Cancer Res 2009; 15:812-20.
41. Yegnasubramanian S, Haffner MC, Zhang Y, Gurel B, Cornish TC, Wu Z, et al. DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity. Cancer Res 2008; 68:8954-67.
42. Lee JJ, Geli J, Larsson C, Wallin G, Karimi M, Zedenius J, et al. Gene-specific promoter hypermethylation without global hypomethylation in follicular thyroid cancer. Int J Oncol 2008; 33:861-9.
43. Martínez-Chantar ML, Vázquez-Chantada M, Ariz U, Martínez N, Varela M, Luka Z, et al. Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice. Hepatology 2008; 47:1191-9.